Trials / Recruiting
RecruitingNCT05241405
Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer
Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer - Randomized, Placebo-controlled, Double-blind Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 354 (estimated)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American ginseng combined with vitamin C from extract of Camu Camu berries
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | QISENG | 2 capsules/day for 8 weeks. |
| DIETARY_SUPPLEMENT | PLACEBO | 2 capsules/day for 8 weeks. |
Timeline
- Start date
- 2022-09-27
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
- First posted
- 2022-02-15
- Last updated
- 2024-10-01
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05241405. Inclusion in this directory is not an endorsement.